Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02138786
Title Study of Selinexor (KPT-330) in Patients With Refractory and/or Relapsed Richter's Transformation (RT)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karyopharm Therapeutics, Inc
Age Groups: adult
Covered Countries USA | ESP | DEU

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
University of California-Los Angeles Santa Monica California 90404 United States Details
Winship Cancer Institute / Emory University Atlanta Georgia 30322 United States Details
Weill Cornell Medical College New York New York 10065 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43202 United States Details
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 United States Details
University of Ulm Ulm Baden-Württemberg 89081 Germany Details
University Hospital of Cologne Koeln 50937 Germany Details
Malopolskie Centrum Medyczne Kraków 30-510 Poland Details
Copernicus Memorial Hospital, Department of Hematology Lodz 93-513 Poland Details
Maria Skłodowska-Curie Institue of Oncology Warszawa 02-034 Poland Details
Instituto Clinico Navarra, Pamplona Pamplona Navarra 31008 Spain Details
Institut Català d'Oncologia Av. Barcelona 08010 Spain Details
Hospital Vall Hebron Barcelona 08035 Spain Details
The Royal Marsden NHS Foundation Trust Sutton Surrey SM2 5PT United Kingdom Details
Churchill Hospital: Cancer and Haematology Centre Oxford OX3 8JL United Kingdom Details
*Shaded cells indicate that there was no data available from for the field